Clinical Trial Update: Afatinib in Patients with Fanconi Anemia (FA) and Advanced Head and Neck Squamous Cell Carcinoma (HNSCC) [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating afatinib for patients with Fanconi anemia and advanced head and neck squamous cell carcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fanconi Anemia
• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Afatinib (afatinib)

Snippet

Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | Conditions: Fanconi Anemia, Head and Neck Squamous Cell Carcinoma | Phase 1, Phase 2 | Status: RECRUITING